Oxaydo is a drug owned by Zyla Life Sciences Us Inc. It is protected by 6 US drug patents filed from 2013 to 2016. Out of these, 1 drug patents are active and 5 have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Mar 16, 2025. Details of Oxaydo's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US7201920 | Methods and compositions for deterring abuse of opioid containing dosage forms |
Mar, 2025
(2 months from now) | Active |
| US9492443 | Abuse deterrent compositions and methods of making same |
May, 2024
(6 months ago) |
Expired
|
| US8409616 | Extended release opioid abuse deterrent compositions and methods of making same |
Nov, 2023
(1 year, 23 days ago) |
Expired
|
| US8637540 | Compositions for deterring abuse of opioid containing dosage forms |
Nov, 2023
(1 year, 23 days ago) |
Expired
|
| US7510726 | Methods and compositions for deterring abuse of opioid containing dosage forms |
Nov, 2023
(1 year, 23 days ago) |
Expired
|
| US7981439 | Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof |
Nov, 2023
(1 year, 23 days ago) |
Expired
|
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Oxaydo's patents.
Latest Legal Activities on Oxaydo's Patents
Given below is the list of recent legal activities going on the following patents of Oxaydo.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Maintenance Fee Reminder Mailed Critical | 08 Jul, 2024 | US9492443 |
| Expire Patent Critical | 21 Aug, 2023 | US7981439 |
| Maintenance Fee Reminder Mailed Critical | 06 Mar, 2023 | US7981439 |
| Change in Power of Attorney (May Include Associate POA) Critical | 15 Mar, 2022 | US8637540 |
| Change in Power of Attorney (May Include Associate POA) Critical | 15 Mar, 2022 | US9492443 |
| Email Notification Critical | 15 Mar, 2022 | US8637540 |
| Email Notification Critical | 15 Mar, 2022 | US9492443 |
| Change in Power of Attorney (May Include Associate POA) Critical | 14 Mar, 2022 | US7201920 |
| Email Notification Critical | 14 Mar, 2022 | US7201920 |
| Change in Power of Attorney (May Include Associate POA) Critical | 14 Mar, 2022 | US8409616 |
US patents provide insights into the exclusivity only within the United States, but Oxaydo is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Oxaydo's family patents as well as insights into ongoing legal events on those patents.
Oxaydo's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Oxaydo's generic launch date based on the expiry of its last outstanding patent is estimated to be Mar 16, 2025 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Oxaydo Generic API suppliers:
Oxycodone Hydrochloride is the generic name for the brand Oxaydo. 26 different companies have already filed for the generic of Oxaydo, with Epic Pharma Llc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Oxaydo's generic
How can I launch a generic of Oxaydo before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Oxaydo's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Oxaydo's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Oxaydo -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 5 mg and 7.5 mg | 07 Feb, 2012 | 1 | 16 Mar, 2025 | Extinguished |
Alternative Brands for Oxaydo
There are several other brand drugs using the same active ingredient (Oxycodone Hydrochloride) as Oxaydo. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | ||
|---|---|---|---|
| Mallinckrodt Inc |
| ||
| Pfizer |
| ||
| Protega Pharms |
| ||
| Purdue Pharma Lp |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Oxycodone Hydrochloride, Oxaydo's active ingredient. Check the complete list of approved generic manufacturers for Oxaydo
About Oxaydo
Oxaydo is a drug owned by Zyla Life Sciences Us Inc. Oxaydo uses Oxycodone Hydrochloride as an active ingredient. Oxaydo was launched by Zyla in 2011.
Approval Date:
Oxaydo was approved by FDA for market use on 17 June, 2011.
Active Ingredient:
Oxaydo uses Oxycodone Hydrochloride as the active ingredient. Check out other Drugs and Companies using Oxycodone Hydrochloride ingredient
Dosage:
Oxaydo is available in tablet form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 7.5MG | TABLET | Discontinued | ORAL |
| 5MG | TABLET | Discontinued | ORAL |